Evaluation of the efficacy of Spinal-Z on patients with gastrointestinal cancer
- Conditions
- Gastrointestinal Cancer.Malignant neoplasm: Ill-defined sites within the digestive system
- Registration Number
- IRCT201612051165N15
- Lead Sponsor
- Baqiyatallah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 61
Patient with age of 25-75 year-old; Patients with gastric adenocarcinoma or Esophageal squamous cell carcinoma with standard treatment during the study; No sign of metastasis in the patients.
Exclusion criteria: Participate in the study with use of any other drugs; history of bone marrow or stem cells transplants; Comorbidities include active infection, respiratory failure, heart failure or left ventricular EF <50%, inflammatory disorders, including rheumatoid arthritis and gout false, thyroid disorders or a history of thyroid antibodies, hyperviscosity syndrome, osteoporosis, anemia, bone marrow disorders such as sickle cell form, thalassemia or myelodysplastic syndrome, immune deficiency and psychiatric diseases that decreases the patient's tolerance; Pregnancy or lactation; Serum creatinine more than 1.5 times the maximum amount of the normal range; AST and ALT more than 1.5 times the upper limit of normal; Alkaline phosphatase greater than 2.5 times the upper limit of the normal range; Bilirubin more than 1.5 mg/dl.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Type of cancer. Timepoint: Before and after of intervention. Method of measurement: Examination and Diagnostic procedures.;Length of the cancer. Timepoint: During the study. Method of measurement: Examination and Diagnostic procedures.
- Secondary Outcome Measures
Name Time Method Pathology. Timepoint: Before and after of intervention. Method of measurement: Laboratory.;Drug Adverse effects. Timepoint: During the study. Method of measurement: History and physical examination.;Quality of life. Timepoint: Before and after of intervention. Method of measurement: Questionnaire.;Gastrointestinal signs: Abdominal pain, Heart burn, Constipation and vomiting. Timepoint: Before and after of intervention. Method of measurement: History and physical examination.